- 24/7 Wall St.•3 hours ago
December 8, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in Thursday’s session. On the NYSE, advancers led decliners by about 3 to 2 and on ...
- Investopedia•6 hours ago
Novartis said its Zykadia drug was twice as effective against chemotherapy in a Phase 3 trial.
Forget politics. Instead, look for reasonably priced companies with competitive advantages.
NVS : Summary for Novartis AG Common Stock - Yahoo Finance
Novartis AG (NVS)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||67.59 x 1400|
|Ask||67.63 x 400|
|Day's Range||66.93 - 67.65|
|52 Week Range||66.93 - 88.49|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||23.83|
|Dividend & Yield||2.72 (3.94%)|
|1y Target Est||N/A|